Form 4: Passage BIO: Insider Buys 673,759 Shares

Lynx1 Capital Management LP and Weston Nichols report acquiring a significant stake in Passage BIO, Inc. through multiple share purchases.

Summary

• Lynx1 Capital Management LP, acting as investment manager for Lynx1 Master Fund LP, acquired 50,055 shares of Passage BIO, Inc. common stock on June 25, 2026.
• The weighted average purchase price for these shares was $4.1175, with individual transactions ranging from $3.33 to $4.30.
• Following these transactions, Lynx1 Capital Management LP beneficially owns 673,759 shares of Passage BIO, Inc. common stock.
• Weston Nichols, as the sole member of the general partner of the investment manager, is also associated with this beneficial ownership, though he disclaims pecuniary interest beyond his role.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development due to the substantial acquisition of shares by a significant investor, indicating strong conviction in the company's value.

Positives

• Significant insider acquisition of shares, indicating confidence from a major investor.
• Acquisition of 673,759 shares demonstrates a substantial increase in beneficial ownership.
• Purchases made across a range of prices ($3.33 to $4.30) suggest opportunistic buying.

Negatives

• The filing does not contain any negative financial results or operational setbacks.

Risks

• The filing does not explicitly mention any current issues or potential future challenges.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing, which is a statement of changes in beneficial ownership.

Management Comments

• The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
• Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

Industry Context

StockSavvy.ai notes that significant insider purchases, especially by 10% owners or investment managers, can often signal a belief in the company's future prospects within the biotechnology sector, which is characterized by high-risk, high-reward potential.

Stakeholder Impact

• Shareholders may view this significant insider purchase positively, potentially signaling confidence in the company's future performance and stock value.
• The increased beneficial ownership by Lynx1 Capital Management LP could influence future corporate governance decisions.

Next Steps

• The reporting persons have undertaken to provide detailed transaction information upon request from the SEC, the Issuer, or security holders.

Key Dates

Recommendation

While the insider purchase is a positive signal, this Form 4 filing solely reports changes in beneficial ownership and does not contain operational or financial results. Therefore, a 'hold' recommendation is appropriate, pending further information on the company's performance and strategy.

Keywords

Passage BIO, PASG, Insider Trading, Form 4, Beneficial Ownership, Lynx1 Capital Management LP, Weston Nichols, Stock Purchase